Viral Load Versus CD4⁺ Monitoring and 5-Year Outcomes of Antiretroviral Therapy in HIV-Positive Children in Southern Africa: a Cohort-Based Modelling Study

Hdl Handle:
http://hdl.handle.net/10144/618880
Title:
Viral Load Versus CD4⁺ Monitoring and 5-Year Outcomes of Antiretroviral Therapy in HIV-Positive Children in Southern Africa: a Cohort-Based Modelling Study
Authors:
Salazar-Vizcaya, L; Keiser, O; Karl, T; Davies, MA; Haas, Andreas D; Blaser, N; Cox, V; Eley, B; Rabie, H; Moultrie, H; Giddy, J; Wood, R; Egger, M; Estill, J
Journal:
AIDS (London, England)
Abstract:
Many paediatric antiretroviral therapy (ART) programmes in Southern Africa rely on CD4⁺ to monitor ART. We assessed the benefit of replacing CD4⁺ by viral load monitoring.
Publisher:
Lippincott Williams & Wilkins
Issue Date:
23-Oct-2014
URI:
http://hdl.handle.net/10144/618880
PubMed ID:
25392857
Submitted date:
2017-03-30
Language:
en
ISSN:
1473-5571
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorSalazar-Vizcaya, Len
dc.contributor.authorKeiser, Oen
dc.contributor.authorKarl, Ten
dc.contributor.authorDavies, MAen
dc.contributor.authorHaas, Andreas Den
dc.contributor.authorBlaser, Nen
dc.contributor.authorCox, Ven
dc.contributor.authorEley, Ben
dc.contributor.authorRabie, Hen
dc.contributor.authorMoultrie, Hen
dc.contributor.authorGiddy, Jen
dc.contributor.authorWood, Ren
dc.contributor.authorEgger, Men
dc.contributor.authorEstill, Jen
dc.date.accessioned2017-03-31T18:28:38Z-
dc.date.available2017-03-31T18:28:38Z-
dc.date.issued2014-10-23-
dc.date.submitted2017-03-30-
dc.identifier.citationViral Load Versus CD4⁺ Monitoring and 5-Year Outcomes of Antiretroviral Therapy in HIV-Positive Children in Southern Africa: a Cohort-Based Modelling Study. 2014, 28 (16):2451-60 AIDSen
dc.identifier.issn1473-5571-
dc.identifier.pmid25392857-
dc.identifier.urihttp://hdl.handle.net/10144/618880-
dc.description.abstractMany paediatric antiretroviral therapy (ART) programmes in Southern Africa rely on CD4⁺ to monitor ART. We assessed the benefit of replacing CD4⁺ by viral load monitoring.en
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subjectviral loaden
dc.subject.meshAdolescenten
dc.subject.meshAfrica, Southernen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshCD4-Positive T-Lymphocytesen
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshCohort Studiesen
dc.subject.meshDrug Monitoringen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshInfanten
dc.subject.meshMaleen
dc.subject.meshModels, Theoreticalen
dc.subject.meshSurvival Analysisen
dc.subject.meshTreatment Outcomeen
dc.subject.meshViral Loaden
dc.titleViral Load Versus CD4⁺ Monitoring and 5-Year Outcomes of Antiretroviral Therapy in HIV-Positive Children in Southern Africa: a Cohort-Based Modelling Studyen
dc.identifier.journalAIDS (London, England)en

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.